Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | DCO | EMBJ |
|---|---|---|
| Price | $172.85 | $75.27 |
| Change today | ▼ 1.45% | ▲ 0.08% |
| Market cap | $2.61B | $13.39B |
| Return, 3 months | -3.9% | +14.3% |
| Return, year to date | +81.7% | +18.4% |
| Return, 1 year | +78.5% | +30.9% |
| P/E (TTM) | -116.8 | 30.5 |
| P/B | 3.8 | 3.9 |
| P/E percentile vs own 5y | 2nd | 64th |
| Dividend yield | – | 1.04% |
| Revenue growth (YoY, latest qtr) | +4.9% | +22.9% |
| Net profit growth (YoY) | -272.3% | +208.7% |
| Gross margin | 26.9% | 17.9% |
| Operating margin | 9.4% | 8.9% |
| Net margin | -4.1% | 5.3% |
| Return on equity | -5.0% | 13.1% |
| Analyst target vs. price | +22.6% | +19.6% |
| Analyst buy share | 80% | 83% |
| RSI (14) | 50 | 52 |
| 30-day volatility | 34.7% | 24.3% |
| Max drawdown, 1 year | -20.5% | -32.2% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
